All hedge funds or institutions that manage over $100M are required by the SEC to file quarterly reports on their holdings.
These reports are called 13F reports. However, the filings are required
the following quarter
from the reporting period,
which means that by the time the filing is made (and we see them), the information could be five months old.
For funds
with long term positions that make few trades, the holdings might closely resemble their current holdings, even after several months. However, for funds that have high turnover,
the holdings data we see might differ significantly from their current holdings. Institutions are required to report CALL and PUT options, and those positions
are identified in the table. However, they are not required to report short positions.
Click the link icon to see the full transaction history.
Upgrade
to unlock premium data and export to Excel 
.
| Security |
Imputed
Share Price |
Prev
Shares |
Current
Shares |
Change
(Percent) |
Prev Value
(USD x1000) |
Current Value
(USD x1000) |
Change
(Percent) |
|---|
| / Achaogen Inc
|
|
|
|
|
|
|
|
| YMTX / Yumanity Therapeutics Inc
|
|
|
|
|
|
|
|
| 17K / Self Storage Group ASA
|
|
|
|
|
|
|
|
| OMED / OptMed Inc
|
|
|
|
|
|
|
|
| US0153511094 / Alexion Pharmaceuticals, Inc.
|
|
|
|
|
|
|
|
| FAST / Fastenal Company
|
|
|
|
|
|
|
|
| 018490100 / Allergan plc Call
|
|
|
|
|
|
|
|
| CMRX / Chimerix, Inc.
|
|
|
|
|
|
|
|
| BMYMP / Bristol-Myers Squibb Company - Preferred Security Call
|
|
|
|
|
|
|
|
| EXAS / Exact Sciences Corporation Put
|
|
|
|
|
|
|
|
| EDIT / Editas Medicine, Inc.
|
|
|
|
|
|
|
|
| GILD / Gilead Sciences, Inc. Call
|
|
|
|
|
|
|
|
| CYTK / Cytokinetics, Incorporated
|
|
|
|
|
|
|
|
| LIFE / aTyr Pharma, Inc.
|
|
|
|
|
|
|
|
| CCXI / ChemoCentryx Inc
|
|
|
|
|
|
|
|
| IRWD / Ironwood Pharmaceuticals, Inc.
|
|
|
|
|
|
|
|
| IRWD / Ironwood Pharmaceuticals, Inc. Call
|
|
|
|
|
|
|
|
| BMY / Bristol-Myers Squibb Company
|
|
|
|
|
|
|
|
| SYRS / Syros Pharmaceuticals, Inc.
|
|
|
|
|
|
|
|
| NBRV / Nabriva Therapeutics Plc
|
|
|
|
|
|
|
|
| AGIO / Agios Pharmaceuticals, Inc.
|
|
|
|
|
|
|
|
| NTLA / Intellia Therapeutics, Inc.
|
|
|
|
|
|
|
|
| ONCE / Spark Therapeutics, Inc.
|
|
|
|
|
|
|
|
| US88339KAA07 / Theravance Biopharma, Inc. Bond
|
|
|
|
|
|
|
|
| DERM / Journey Medical Corporation
|
|
|
|
|
|
|
|
| TMBR / Timber Pharmaceuticals Inc
|
|
|
|
|
|
|
|
| ZCOR / Zyla Life Sciences
|
|
|
|
|
|
|
|
| US33830X1046 / Five Prime Therapeutics Inc
|
|
|
|
|
|
|
|
| ACRS / Aclaris Therapeutics, Inc.
|
|
|
|
|
|
|
|
| BGNE / BeiGene, Ltd. - Depositary Receipt (Common Stock)
|
|
|
|
|
|
|
|
| ARDX / Ardelyx, Inc.
|
|
|
|
|
|
|
|
| ASMB / Assembly Biosciences, Inc.
|
|
|
|
|
|
|
|
| FATE / Fate Therapeutics, Inc.
|
|
|
|
|
|
|
|
| GLPG / Galapagos NV - Depositary Receipt (Common Stock)
|
|
|
|
|
|
|
|
| ADVM / Adverum Biotechnologies, Inc.
|
|
|
|
|
|
|
|
| SNDX / Syndax Pharmaceuticals, Inc.
|
|
|
|
|
|
|
|
| CASC / Cascadian Therapeutics, Inc. Call
|
|
|
|
|
|
|
|
| ASND / Ascendis Pharma A/S - Depositary Receipt (Common Stock)
|
|
|
|
|
|
|
|
| KURA / Kura Oncology, Inc.
|
|
|
|
|
|
|
|
| ATRA / Atara Biotherapeutics, Inc.
|
|
|
|
|
|
|
|
| XNCR / Xencor, Inc.
|
|
|
|
|
|
|
|
